These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9687155

  • 21. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H, Kurian SM, Hendy GN, White J, deLuca HF, Evans CO, Nanes MS.
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [Abstract] [Full Text] [Related]

  • 22. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C.
    J Mol Biol; 2005 Jun 03; 349(2):248-60. PubMed ID: 15890193
    [Abstract] [Full Text] [Related]

  • 23. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
    Healy KD, Zella JB, Prahl JM, DeLuca HF.
    Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):9733-7. PubMed ID: 12900504
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70.
    Muscat GE, Burke LJ, Downes M.
    Nucleic Acids Res; 1998 Jun 15; 26(12):2899-907. PubMed ID: 9611234
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D.
    Nguyen TM, Adiceam P, Kottler ML, Guillozo H, Rizk-Rabin M, Brouillard F, Lagier P, Palix C, Garnier JM, Garabedian M.
    J Bone Miner Res; 2002 Sep 15; 17(9):1728-37. PubMed ID: 12211444
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhäger JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB.
    Endocrinology; 1996 May 15; 137(5):2001-11. PubMed ID: 8612541
    [Abstract] [Full Text] [Related]

  • 34. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC, Quach HP, Vieth R, Pang KS.
    Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E977-89. PubMed ID: 23482451
    [Abstract] [Full Text] [Related]

  • 35. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
    Malloy PJ, Zhu W, Zhao XY, Pehling GB, Feldman D.
    Mol Genet Metab; 2001 Jun 01; 73(2):138-48. PubMed ID: 11386849
    [Abstract] [Full Text] [Related]

  • 36. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y, Pike JW, Koeffler HP.
    Leuk Res; 1995 Mar 01; 19(3):147-58. PubMed ID: 7700077
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.